GBIO
Generation Bio Co
NASDAQ: GBIO · HEALTHCARE · BIOTECHNOLOGY
$5.34
+0.00% today
Updated 2026-02-09
Market cap
$35.98M
P/E ratio
—
P/S ratio
2.36x
EPS (TTM)
$-9.37
Dividend yield
—
52W range
$3 – $7
Volume
0.1M
Generation Bio Co (GBIO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-20.20%
ROE
-0.81%
ROA
-0.27%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $36000.00 | $-35.80M | 100.00% | -103,594.44% | -99,452.78% |
| 2019 | $0.00 | $-60.33M | — | — | — |
| 2020 | $0.00 | $-76.50M | — | — | — |
| 2021 | $0.00 | $-114.67M | — | — | — |
| 2022 | $880000.00 | $-132.10M | -582.95% | -16,043.41% | -15,010.91% |
| 2023 | $5.90M | $-126.61M | 100.00% | -2,346.93% | -2,144.51% |
| 2024 | $19.89M | $-131.67M | 100.00% | -715.82% | -661.91% |